Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation

T G Lehmann1, T A Koeppel, M Kirschfink

  • 1Department of General Surgery, University of Heidelberg, Germany.

Transplantation
|October 15, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.

Archives of surgery (Chicago, Ill. : 1960)·2000
Same author

[More attention to hernia surgery!].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2000
Same author

Sequential (domino) transplantation of the liver in a transthyretin-50 familial amyloid polyneuropathy. Special reference to cardiological diagnosis and complications.

Langenbeck's archives of surgery·2000
Same author

Spectrometry supports fluorescence staging laparoscopy after intraperitoneal aminolaevulinic acid lavage for gastrointestinal tumours.

Journal of photochemistry and photobiology. B, Biology·2000
Same author

Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction.

British journal of cancer·2000
Same author

Development of a computer based training program for liver transplantation.

Transplantation proceedings·2000

Complement inhibition using soluble complement receptor type 1 (sCR1) effectively reduces hepatic ischemia/reperfusion injury. This treatment improves microcirculation and graft function in liver transplantation, highlighting complement

Area of Science:

  • Transplantation immunology
  • Vascular biology
  • Organ preservation

Background:

  • The complement system is implicated in ischemia/reperfusion (I/R) injury.
  • Investigating complement's role in liver transplantation is crucial.

Purpose of the Study:

  • To assess the impact of complement inhibition on hepatic microcirculation and graft function.
  • To evaluate soluble complement receptor type 1 (sCR1) efficacy in a rat liver transplant model.

Main Methods:

  • Orthotopic liver transplantation in Lewis rats with cold preservation.
  • Intravenous administration of sCR1 or Ringer's solution before reperfusion.
  • In vivo microscopy to assess microvascular perfusion, leukocyte adhesion, and Kupffer cell activity.

Related Experiment Videos

Main Results:

  • sCR1 significantly improved microvascular perfusion (87% vs. 50%).
  • Reduced leukocyte adhesion in sinusoids and venules post-sCR1 treatment.
  • Decreased Kupffer cell activity and increased bile production (200%) with sCR1.
  • Lowered liver enzyme activity indicating reduced parenchymal injury.

Conclusions:

  • Complement system plays a critical role in hepatic I/R injury.
  • sCR1 is an effective therapeutic strategy to mitigate reperfusion injury in liver transplantation.